A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: poor quality (76), poor (225), cheap (4)

Atezolizumab (1875mg 21-days) SC

Description
Chemotherapy Protocol UROTHELIAL CANCER Atezolizumab SC (1875mg – 21 days) Regimen • Urothelial cancer – Atezolizumab
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Atezolizumab-SC-1875mg-21-days.pdf

Glofitamab-Obinutuzumab

Description
Chemotherapy Protocol LYMPHOMA GLOFITAMAB-OBINUTUZUMAB Regimen • Lymphoma-Glofitamab-Obinutuzumab Indication • Treatment of adu
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Glofitamab-Obinutuzumab.pdf

InP-Cisplatin-Doxorubicin-Methotrexate (1-4)

Description
Chemotherapy Protocol Sarcoma CISPLATIN-DOXORUBICIN-METHOTREXATE (cycles 1-4) Inpatient Regimen There are multiple
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InP-Cisplatin-Doxorubicin-Methotrexate-1-4.pdf

Diarrhoea - patient information

Description
Patient information factsheet Diarrhoea Diarrhoea is passing looser or more frequent stools than is normal for you. It a
Url
/Media/UHS-website-2019/Patientinformation/Generalmedicine/Diarrhoea-1360-PIL.pdf

Carboplatin(AUC6)-Pemetrexed

Description
Chemotherapy Protocol MESOTHELIOMA CARBOPLATIN (AUC6)-PEMETREXED Regimen • Mesothelioma – Carboplatin (AUC6)-Pemetrexed
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Mesothelioma/CarboplatinAUC6-Pemetrexed-Ver1.5.pdf

Carboplatin and Pemetrexed

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN-PEMETREXED Regimen • NSCLC – Carboplatin-Pemetrex
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-Pemetrexed-Ver1.4.pdf

UHS Inclusion and Belonging Strategy

Description
Our strategy sets out clear actions we will take to make UHS a place where every person feels they belong and
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Equality-reports/uhs-inclusion-and-belonging-strategy.pdf

Cytarabine1500

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE (1500mg/m2) In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Cytarabine (1500mg/m2) Indication • Consolidation
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Cytarabine1500.pdf

Cytarabine(SC)-Venetoclax

Description
Chemotherapy Protocol Acute Myeloid Leukaemia CYTARABINE (SC) - VENETOCLAX Regimen  AML – Cytarabine (SC) -Venetoclax Indication  Ne
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/CytarabineSC-Venetoclax.pdf

Papers Council of Governors 20 July 2022

Description
Agenda attachments 1 CoG Agenda - 20.07.2022.docx Date Time Location Chair Agenda Council of Governors 20/07
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/Papers-Council-of-Governors-20-July-2022.pdf
141 to 150 of 266
Previous … 13 14 15 16 17 … Next